Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | BMRN | TECH | ||
| Company | Acceleron Pharma | Biomarin Pharmaceuticals | Bio-Techne Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 62.40 | 68.60 | ||
| High | 179.85 | 63.76 | 71.32 | ||
| Low | 177.06 | 61.41 | 68.42 | ||
| Last | 178.75 | 63.45 | 71.05 | ||
| Change | -0.93 | +0.89 | +2.33 | ||
| % Change | -0.52% | +1.42% | +3.39% | ||
| Volume | 7,884,200 | 1,267,957 | 1,332,813 | ||
| 20-Day Average Volume | 1,302,050 | 1,572,532 | 1,213,912 | ||
| Previous Close | 179.68 | 62.56 | 68.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 65.96 | 72.74 | ||
| 20-Day Raw Stochastic | 84.01% | 23.86% | 36.37% | ||
| 20-Day Relative Strength | 70.12% | 33.56% | 47.25% | ||
| Weighted Alpha | +57.78 | -33.61 | +4.34 | ||
| Today's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -3.21% since 11/14/24 | -1.94% since 11/14/24 | ||
| Low | 173.17 on 11/16/21 | 61.15 on 11/19/24 | 65.61 on 11/20/24 | ||
| High | 179.94 on 11/17/21 | 66.05 on 11/15/24 | 72.46 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -9.65% since 10/21/24 | +1.10% since 10/21/24 | ||
| Low | 172.25 on 10/20/21 | 61.15 on 11/19/24 | 65.61 on 11/20/24 | ||
| High | 179.94 on 11/17/21 | 70.98 on 10/25/24 | 80.80 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -31.41% since 08/21/24 | -2.09% since 08/21/24 | ||
| Low | 120.20 on 08/20/21 | 61.15 on 11/19/24 | 65.61 on 11/20/24 | ||
| High | 189.99 on 09/29/21 | 93.04 on 08/29/24 | 80.95 on 09/19/24 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | -17.90% since 05/21/24 | -13.96% since 05/21/24 | ||
| Low | 113.49 on 07/15/21 | 61.15 on 11/19/24 | 65.61 on 11/20/24 | ||
| High | 189.99 on 09/29/21 | 94.85 on 08/20/24 | 83.96 on 05/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,922,872 | 10,919,058 | ||
| Shares Outstanding, K | 61,156 | 190,583 | 158,892 | ||
| Annual Sales | 92,520,000 | 2,419,230,000 | 1,159,060,000 | ||
| Annual Net Income | -166,030,000 | 167,650,000 | 168,110,000 | ||
| Last Quarter Sales | 34,200,000 | 745,740,000 | 289,460,000 | ||
| Last Quarter Net Income | -70,470,000 | 106,080,000 | 33,600,000 | ||
| 60-Month Beta | 0.13 | 0.31 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 0.91 on 10/29/24 | 0.42 on 10/30/24 | ||
| Latest Earnings Date | 11/04/21 | 10/29/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 11/08/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 11/08/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.42 | 40.72 | ||